Larimar Therapeutics, Inc. — Director's Dealing 2016

Jul 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ZAFGEN, INC. (ZFGN)
CIK: 0001374690
Period of Report: 2016-06-30

Reporting Person: LAMATTINA JOHN L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-30	Stock Option (Right to Buy)	$5.99	A	12000	Acquired	2026-06-30	Common Stock (12000)	Direct

Footnotes

F1: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 30, 2017 or the date of the 2017 annual meeting of stockholders, subject to the director's continued service on the board of directors.